Most Read Articles
one year ago
Multi-parametric MRI (mpMRI) can recognize prostate tumours in the loco-regional assessment of men with early prostate cancer based on a study.
Jairia Dela Cruz, one year ago
Smoking rates are worryingly high in Asia, with the number of adult smokers reaching 121 million, half of whom live in Indonesia, according to an expert who addressed an audience of oncologists at the recent Asia Pacific Lung Cancer Conference 2016 in Chiang Mai, Thailand.
Dr. David Ettinger, 3 years ago

Lung cancer is one of the most common, yet most preventable cancers. The disease claims about 1 million lives each year worldwide, which is more than prostate, colon and breast cancers combined.

Jackey Suen, one year ago

More biomarkers should be included in the standard molecular testing for lung adenocarcinoma to improve patients’ prognosis and survival, results of the LCMC II (Lung Cancer Mutation Consortium II) study suggest.

IN CONVERSATION: Professor Tony Mok speaks on new and upcoming therapies for ALK-positive lung cancer

5 months ago
IN CONVERSATION: Professor Tony Mok speaks on new and upcoming therapies for ALK-positive lung cancer
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
one year ago
Multi-parametric MRI (mpMRI) can recognize prostate tumours in the loco-regional assessment of men with early prostate cancer based on a study.
Jairia Dela Cruz, one year ago
Smoking rates are worryingly high in Asia, with the number of adult smokers reaching 121 million, half of whom live in Indonesia, according to an expert who addressed an audience of oncologists at the recent Asia Pacific Lung Cancer Conference 2016 in Chiang Mai, Thailand.
Dr. David Ettinger, 3 years ago

Lung cancer is one of the most common, yet most preventable cancers. The disease claims about 1 million lives each year worldwide, which is more than prostate, colon and breast cancers combined.

Jackey Suen, one year ago

More biomarkers should be included in the standard molecular testing for lung adenocarcinoma to improve patients’ prognosis and survival, results of the LCMC II (Lung Cancer Mutation Consortium II) study suggest.